Order Article Reprints

Li J, Pohl L, Schüler J, Korzeniewski N, Reimold P, Kaczorowski A, Hou W, Zschäbitz S, Nientiedt C, Jäger D, et al. Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery. Biomedicines. 2021; 9(6):627. https://doi.org/10.3390/biomedicines9060627

Li, Jielin, Laura Pohl, Julia Schüler, Nina Korzeniewski, Philipp Reimold, Adam Kaczorowski, Weibin Hou, Stefanie Zschäbitz, Cathleen Nientiedt, Dirk Jäger, and et al. 2021. "Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery" Biomedicines 9, no. 6: 627. https://doi.org/10.3390/biomedicines9060627

Li, J., Pohl, L., Schüler, J., Korzeniewski, N., Reimold, P., Kaczorowski, A., Hou, W., Zschäbitz, S., Nientiedt, C., Jäger, D., Hohenfellner, M., Duensing, A., & Duensing, S. (2021). Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery. Biomedicines, 9(6), 627. https://doi.org/10.3390/biomedicines9060627